Motac Neuroscience offers a wide range of highly-specialised services to support the preclinical development of new treatments for neurodegenerative disorders, including Parkinson's disease and other movement disorders.

State-of-the-art model systems to demonstrate efficacy and mechanism of action of novel drugs are routinely available. These include acute and progressive models of neurodegeneration, Parkinson's disease and drug-induced dyskinesias 

Motac personnel have extensive experience in the fields of neurodegeneration/neuroprotection and movement disorders such as Parkinson's disease. We are, therefore, able to offer expert advice on study design as well as performing studies to a high quality and to agreed timelines.

For further information on the models available, to discuss your requirements or to request a quotation, please contact us at:

info@motac.com